Swega Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 1.04 Cr
as on 14-12-2024
- Company Age 28 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.76 Cr
as on 14-12-2024
- Satisfied Charges ₹ 1.20 M
as on 14-12-2024
- Revenue -22.35%
(FY 2022)
- Profit -20.67%
(FY 2022)
- Ebitda -30.33%
(FY 2022)
- Net Worth 9.63%
(FY 2022)
- Total Assets 1.29%
(FY 2022)
About Swega Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.04 Cr.
The company currently has active open charges totaling ₹6.76 Cr. The company has closed loans amounting to ₹1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Reena Verma, Gyanendra Verma, and Nardev Verma serve as directors at the Company.
- CIN/LLPIN
U24231UP1996PLC020829
- Company No.
020829
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Oct 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Muzaffarnagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Swega Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Reena Verma  | Director | 11-Oct-1996 | Current |
| Gyanendra Verma | Whole-Time Director | 10-Mar-2015 | Current |
| Nardev Verma | Whole-Time Director | 24-Mar-2015 | Current |
Financial Performance of Swega Laboratories.
Swega Laboratories Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 22.35% decrease. The company also saw a substantial fall in profitability, with a 20.67% decrease in profit. The company's net worth moved up by a moderate rise of 9.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swega Laboratories?
In 2021, Swega Laboratories had a promoter holding of 55.62% and a public holding of 44.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Mar 2016 | ₹6.26 Cr | Open |
Uttar Pradesh Financial Corjporation 14/88 Civil Lines ; Creation Date: 10 Sep 1998 | ₹5.00 M | Open |
Union Bank Of India Creation Date: 01 May 1999 | ₹1.20 M | Satisfied |
How Many Employees Work at Swega Laboratories?
Unlock and access historical data on people associated with Swega Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swega Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swega Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
